Teva Financial Statements From 2010 to 2024
| TEV Stock | EUR 21.20 0.70 3.41% |
Check Teva Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Teva Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Teva financial statements analysis is a perfect complement when working with Teva Pharmaceutical Valuation or Volatility modules.
Teva |
Teva Pharmaceutical Industries Company Return On Equity Analysis
Teva Pharmaceutical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Teva Pharmaceutical Return On Equity | -0.24 |
Most of Teva Pharmaceutical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Teva Pharmaceutical Industries is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Teva Pharmaceutical Industries has a Return On Equity of -0.2414. This is 98.99% lower than that of the Healthcare sector and 168.97% lower than that of the Drug Manufacturers - Specialty & Generic industry. The return on equity for all Germany stocks is 22.13% lower than that of the firm.
Teva Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Teva Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Teva Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Teva Pharmaceutical competition to find correlations between indicators driving Teva Pharmaceutical's intrinsic value. More Info.Teva Pharmaceutical Industries is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Teva Pharmaceutical's earnings, one of the primary drivers of an investment's value.About Teva Pharmaceutical Financial Statements
Teva Pharmaceutical stakeholders use historical fundamental indicators, such as Teva Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Teva Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Teva Pharmaceutical's assets and liabilities are reflected in the revenues and expenses on Teva Pharmaceutical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Teva Pharmaceutical Industries. Please read more on our technical analysis and fundamental analysis pages.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel. TEVA PHARMACEUT operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 42535 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Teva Stock
Teva Pharmaceutical financial ratios help investors to determine whether Teva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Teva with respect to the benefits of owning Teva Pharmaceutical security.